Journal article icon

Journal article

Etanercept for the treatment of rheumatoid arthritis.

Abstract:

BACKGROUND: Etanercept is a soluble tumour necrosis factor alpha-receptor disease-modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). OBJECTIVES: The purpose of this review was to update the previous Cochrane systematic review published in 2003 assessing the benefits and harms of etanercept for the treatment of RA. In addition, we also evaluated the benefits and harms of etanercept plus DMARD compared with DMARD monotherapy in those people with RA who are pa...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
Expand authors...
Journal:
Cochrane database of systematic reviews
Volume:
5
Issue:
5
Pages:
CD004525
Publication date:
2013-01-01
DOI:
EISSN:
1469-493X
ISSN:
1469-493X
Source identifiers:
401961
Language:
English
Keywords:
Pubs id:
pubs:401961
UUID:
uuid:3ff200e0-2449-458f-98e7-b1d3b80d045f
Local pid:
pubs:401961
Deposit date:
2013-11-17

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP